Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000987

Drug Information
SynonymsTemozolamide; CHEBI:153686; SMR000466338; 8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one; Temozolomidum [Latin]; LS-80558; TMZ-Bioshuttle; AC1L1K9B; 3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetraazine-8-carboxamide; {Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide,} 3, 4-dihydro-3-methyl-4-oxo-; M&B-39831; CPD000466338; ZINC01482184; CHEMBL810; NCI60_003316; Sch-52365; 85622-93-1; HMS2090B08; NSC-362856; NSC362856; Temozolomide [INN:BAN]; C047246; temozolomide; CCRG-81045; Bio-0147; MB 39831; 3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide; M&B 39831; NSC 362856; NCGC00167429-02; 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide; Schering brand of temozolomide; Temozolomidum; D06067; CCRIS 8996; Temodal; I14-1943; MLS002701861; 3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide; M-39831; DB00853; Temodal (TN); Schering-Plough brand of temozolomide; UNII-YF1K15M17Y; TL8005593; Imidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-; Essex brand of temozolomide; 3,4-Dihydro-3-methyl-4-oxoimidazo(5,1-d)-1,2,3,5-tetrazine-8-carboxamide; Sch 52365; Methazolastone; C6H6N6O2; M B 39831; Temozolomide (JAN/USAN/INN); I06-0149; Temozolodida; HMS2051O12; Temozolodida [Spanish]; Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-; 3-Methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide; AC-758; SAM001246636; MLS001424028; STK623541; Temodar; BRN 5547136; CID5394; CCRG 81045; NCGC00167429-01; M & B 39831; MLS000759447; BIDD:GT0204
Trade NameTemodar; Temodal
IndicationGrade IV astrocytoma
[ICD9: 191   ICD10: C71]
Approved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCN1C(=O)N2C=NC(=C2N=N1)C(=O)N    
Therapeutic ClassAntineoplastic Agents
CAS NumberCAS 85622-93-1
PubChem Compound IDCID 5394.
PubChem Substance IDSID 225666.
SuperDrug ATC IDL01AX03
SuperDrug CAS ID085622931;
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2DNA ligase IV as a new molecular target for temozolomide. Biochem Biophys Res Commun. 2009 Jul 15. [Epub ahead of print] To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543